Published in Physician Law Weekly, October 27th, 2004
CCS is "a very rare soft tissue sarcoma with a poor prognosis," oncologists in Japan explained. "It has become apparent through immunohistochemical, ultrastructural, and microarray analyses that CCS is a soft tissue melanocytic neoplasm."
"Alterations in the p16INK4a/p14ARF gene are common in malignant melanoma, which is the prototypical melanocytic neoplasm," noted T. Takahira and colleagues at Kyushu University. In a recent study, they "performed a clinicopathologic analysis and investigated p16 and cyclin D1 expression by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly